Name: Impedimed (IPD) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

IPD

Impedimed

Health Care Equipment & Services

Impedimed is a global leader in medical technology, specializing in the development and sale of devices using bioimpedance spectroscopy for noninvasive clinical assessment. The company focuses on addressing the challenges of secondary lymphedema, particularly related to breast cancer, through innovative solutions like the SOZO® Digital Health Platform. With operations in the US, Europe, and Australia, Impedimed is committed to improving patient outcomes by setting new standards of care.

Short position

short percentage0.00%

reported shorts99.8K

shares on issue3.660B

Impedimed (ASX:IPD) has 0.00% of its shares on issue reported as short positions as of 29 June 2026, or about 99,795 shares. Over the past 30 days that figure has fallen 0.41 percentage points, and over 90 days it has fallen 0.53 percentage points. Its highest recorded short interest was 7.14% in May 2017. IPD is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.